NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

RecruitingPhase 2, Phase 3

Sponsor: Genesis Athens Clinic

Conditions: Infertility, Female, Anovulatory Infertility, Menopause, Amenorrhea

Interventions: Autologous PRP intra ovarian infusion, Autologous PFP intra ovarian infusion

Countries: Greece

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.

Eligibility overview

Sex: FEMALE

Age: 45 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Age between 45-55 years old
* Amenorrhea for at least 12 months
* Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment.
* Willing to comply with study requirements

Exclusion Criteria:

* Any pathological disorder related to reproductive system anatomy
* Previous POI diagnosis
* Abnormal karyotype
* Endometriosis
* Adenomyosis
* Fibroids and adhesions
* Infections in reproductive system
* Current or previous diagnosis of reproductive system cancer
* History of familiar cancer in reproductive system
* Severe male factor infertility
* Prior referral for PGT
* Ovarian inaccessibility
* Endocrinological disorders (Hypothalamus-Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
* BMI\>30 kg/m2 or BMI\<18.5 kg/m2
* Systematic autoimmune disorders

Locations (1)

Athens, Greece